Biologically Active Small Molecules

EPA is an &omega-3 fatty acid abundantly available in marine organisms. (&plusmn)17(18)-DiHETE is one of the major metabolites produced when EPA is incubated with various rat tissue homogenates or cynomolgus monkey seminal vesicles.

A derivative of EPA derived via epoxidation of the 17,18-double bond of EPA a potent and selective activator of BK-type calcium-activated potassium ion channels in vascular smooth muscle cells.

A derivative of EPA derived via epoxidation of the 17,18-double bond of EPA a potent and selective activator of BK-type calcium-activated potassium ion channels in vascular smooth muscle cells.

A derivative of EPA derived via epoxidation of the 17,18-double bond of EPA a potent and selective activator of BK-type calcium-activated potassium ion channels in vascular smooth muscle cells.

A derivative of EPA derived via epoxidation of the 17,18-double bond of EPA a potent and selective activator of BK-type calcium-activated potassium ion channels in vascular smooth muscle cells.

(&plusmn)17-HDHA is an autoxidation product of DHA in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.

(&plusmn)17-HDHA is an autoxidation product of DHA in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.

(&plusmn)17-HDHA is an autoxidation product of DHA in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.

(&plusmn)17-HDHA is an autoxidation product of DHA in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.

The racemic version of a CYP450 metabolite of arachidonic acid that potently inhibits proximal tubule ATPase activity.

The racemic version of a CYP450 metabolite of arachidonic acid that potently inhibits proximal tubule ATPase activity.

The racemic version of a CYP450 metabolite of arachidonic acid that potently inhibits proximal tubule ATPase activity.